Related Experiment Video
Updated: Sep 30, 2025
09:29
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
18.2K
Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer
Yixiao Zhang1,2, Lisha Sun1,2,3, Haonan Li4
1Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Elife
|March 14, 2022
Summary
Talin 1 (TLN1) is upregulated in triple-negative breast cancer (TNBC) and drives metastasis. A novel compound, C67399, targets TLN1 and integrin β1, showing promise for TNBC treatment by inhibiting tumor cell migration.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Integrins are critical for triple-negative breast cancer (TNBC) metastasis.
- The role of talin 1 (TLN1), an integrin-independent factor, in TNBC metastasis is not well understood.
Purpose of the Study:
- To investigate the role of TLN1 in TNBC metastasis.
- To identify and evaluate a small molecule targeting TLN1 and integrin β1 for TNBC treatment.
Main Methods:
- Bioinformatics analysis of TCGA and Shengjing Hospital cohorts.
- Western blot and RT-PCR to assess TLN1 and integrin pathway expression.
- Computational screening to identify C67399 targeting the TLN1-integrin β1 interface; xenograft assays for pharmacodynamics.
Main Results:
- TLN1 upregulation in TNBC correlates with metastasis and poor prognosis.
- TLN1 silencing attenuated TNBC cell migration by disrupting focal adhesion dynamics and regulating FAK-AKT signaling and epithelial-mesenchymal transition.
- Targeting TLN1-integrin β1 interaction with C67399 repressed TNBC metastasis.
Conclusions:
- TLN1 overexpression promotes TNBC metastasis.
- The small molecule C67399, targeting TLN1, shows potential as a therapeutic strategy for TNBC.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
13.4K
04:15Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
Published on: February 2, 2024
2.0K
Related Concept Videos
01:17Intracellular Signaling Affects Focal Adhesions
2.9K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.9K
01:15Receptor Downregulation in MVBs
2.2K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.2K
01:16TGF - β Signaling Pathway
7.9K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.9K
01:15Activation of Integrins
3.7K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.7K
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
01:10Integrins
4.2K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
4.2K